Search
Back to Search

TRULICITY

TRULICITY® is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist for use in adults with type 2 diabetes mellitus.

For complete information, visit Lilly

  • Other Medicine
  • Product Specifications
Trulicity_500x500

Device Type:

Medicine Pen

Reusable Disposable:

Disposable (Single dose only)

Medicine Type:

Glucagon-like peptide-1 (GLP-1) receptor agonist

Insulin Type:

N/A

Dose Delivery:

  • 0.75mg/0.5 mL solution in a single-dose pen.
  • 1.5 mg/0.5 mL solution in a single-dose pen.
  • 3 mg/0.5mL solution in a single-dose pen.
  • 4.5 mg/0.5 mL solution in a single-dose pen.

Total Capacity:

  • 0.75 mg per single-dose pen
  • 1.5 mg per single-dose pen
  • 3 mg per single-dose pen
  • 4.5 mg per single-dose pen

Memory Function:

No

Audible Click:

No

Assistive Dexterity Issue Options:

No

ADCES Resources

Manufacturer Programs

Other Programs

For Patients

For HCP

  • Trulicity® (dulaglutide) is available in four separate pens containing a single dose of either 0.75mg, 1.5mg, 3 mg or 4.5 mg for once weekly dosing.
  • The recommended initiating dose of TRULICITY is 0.75 mg subcutaneously once weekly. The dose may be increased to 1.5 mg once weekly for additional glycemic control. If additional glycemic control is needed, increase the dose to 3 mg once weekly after at least 4 weeks on the 1.5 mg dose. If additional glycemic control is needed, increase to the maximum dose of 4.5 mg once weekly after at least 4 weeks on the 3 mg dose.
  • There is no mixing or reconstitution required.
  • The pen is designed with a pre-attached hidden needle.
  • When using TRULICITY with insulin, administer as separate injections and never mix. It is acceptable to inject TRULICITY and insulin in the same body region, but the injections should not be adjacent to each other.

Storage and Handling:

  • Store TRULICITY in the refrigerator at 36°F to 46°F (2°C to 8°C).
  • If needed, each single-dose pen can be kept at room temperature, not to exceed 86°F (30°C) for a total of 14 days.
  • Do not freeze TRULICITY. Do not use TRULICITY if it has been frozen.
  • TRULICITY must be protected from light. Storage of TRULICITY in the original carton is recommended until time of administration.
  • Inspect TRULICITY visually before use. It should appear clear and colorless. Do not use TRULICITY if particulate matter or coloration is seen.

Have a question about this product?
January 2024

The Danatech Digest

Join 25,000+ professionals who get our latest diabetes technology updates

DISCLAIMERS: 

This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.

ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.

danatech is Made Possible by Grant Funding and Industry Sponsorship